{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:12:15Z","timestamp":1793157135854,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Recent studies demonstrate comparable outcomes of Mohs micrographic surgery (MMS) versus local excision (LE) for melanoma in situ. These studies are limited by their focus on the head and neck.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The primary objective was to compare 5-year overall and melanoma-specific mortality among patients with melanoma in situ of the trunk or extremities who undergo MMS versus LE. The secondary objective was to compare 5-year local recurrence among the same cohort of patients who undergo MMS versus LE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>The Surveillance, Epidemiology, and End Results (SEER) database (2000\u20132015) was queried to identify patients who underwent MMS versus LE for melanoma in situ of the trunk, upper extremities, or lower extremities. Outcomes were 5-year recurrence, melanoma-specific mortality, and overall mortality. Multivariable regression analyses were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Thirty three thousand nine hundred eighty-three patients underwent surgical treatment (MMS 3%; LE 97%). In adjusted analyses, there was no difference in local recurrence (hazard ratio [HR] 1.00, 95% confidence interval [CI] 0.56\u20131.78), melanoma-specific mortality (HR 0.89, 95% CI 0.12\u20136.47), nor overall mortality (HR 1.10, 95% CI 0.82\u20131.48) between MMS versus LE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>There is no difference of 5-year local recurrence, melanoma-specific mortality, nor overall mortality associated with MMS versus LE for melanoma in situ of the trunk or extremities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002417","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T02:30:29Z","timestamp":1586399429000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Recurrence and Mortality of Melanoma In Situ of the Trunk or Extremities: A Surveillance, Epidemiology, and End Results Analysis"],"prefix":"10.1097","volume":"47","author":[{"given":"Vijaya T.","family":"Daniel","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Massachusetts, Worcester, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Crawford","sequence":"additional","affiliation":[{"name":"Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina I.","family":"Kiefe","sequence":"additional","affiliation":[{"name":"Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel H.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Massachusetts, Worcester, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"5 Suppl 1","key":"R1-20250731","first-page":"S17","article-title":"Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006","volume":"65","author":"Jemal","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamafacial.2016.1044","article-title":"The increasing incidence of melanoma: it may be more than a freckle","volume":"19","author":"Moyer","year":"2017","journal-title":"JAMA Facial Plast Surg"},{"key":"R6-20250731","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaad.2016.05.011","article-title":"Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: a prospective, observational study","volume":"75","author":"Wei","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jso.21962","article-title":"Evidence-based treatment of early-stage melanoma","volume":"104","author":"Ross","year":"2011","journal-title":"J Surg Oncol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1758834015572284","article-title":"Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications","volume":"7","author":"Grossmann","year":"2015","journal-title":"Ther Adv Med Oncol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaad.2015.03.057","article-title":"Melanoma in situ: Part II. Histopathology, treatment, and clinical management","volume":"73","author":"Higgins","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","article-title":"Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Coit","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamadermatol.2016.6138","article-title":"Outcomes of melanoma in situ treated with Mohs micrographic surgery compared with wide local excision","volume":"153","author":"Nosrati","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","article-title":"AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery","volume":"67","author":"Connolly","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/DSS.0000000000001429","article-title":"Melanoma of the face and Mohs micrographic surgery: nationwide mortality data analysis","volume":"44","author":"Trofymenko","year":"2018","journal-title":"Dermatol Surg"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/dsu.12335","article-title":"Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision","volume":"39","author":"Chin-Lenn","year":"2013","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/DSS.0000000000001715","article-title":"Benefit of Mohs micrographic surgery over wide local excision for melanoma of the head and neck: a rational approach to treatment","volume":"45","author":"Demer","year":"2019","journal-title":"Dermatol Surg"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.suc.2014.07.003","article-title":"Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence","volume":"94","author":"Mrazek","year":"2014","journal-title":"Surg Clin North Am"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2004.08.038","article-title":"Cutaneous head and neck melanoma treated with Mohs micrographic surgery","volume":"52","author":"Bricca","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cll.2011.03.006","article-title":"Melanoma margin assessment","volume":"31","author":"Trotter","year":"2011","journal-title":"Clin Lab Med"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jaad.2015.02.1122","article-title":"National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ","volume":"72","author":"Viola","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1245\/s10434-014-3516-x","article-title":"Cancer recurrence: an important but missing variable in national cancer registry","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R23-20250731","first-page":"599.e591","article-title":"Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology","volume":"71","author":"Mayer","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 23","key":"R24-20250731","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/cncr.29050","article-title":"Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2","volume":"120","author":"Kosary","year":"2014","journal-title":"Cancer"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:50Z","timestamp":1753999970000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002417","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]}}}